37276426|t|CARD9 attenuates Abeta pathology and modifies microglial responses in an Alzheimer's disease mouse model.
37276426|a|Recent advances have highlighted the importance of several innate immune receptors expressed by microglia in Alzheimer's disease (AD). In particular, mounting evidence from AD patients and experimental models indicates pivotal roles for TREM2, CD33, and CD22 in neurodegenerative disease progression. While there is growing interest in targeting these microglial receptors to treat AD, we still lack knowledge of the downstream signaling molecules used by these receptors to orchestrate immune responses in AD. Notably, TREM2, CD33, and CD22 have been described to influence signaling associated with the intracellular adaptor molecule CARD9 to mount downstream immune responses outside of the brain. However, the role of CARD9 in AD remains poorly understood. Here, we show that genetic ablation of CARD9 in the 5xFAD mouse model of AD results in exacerbated amyloid beta (Abeta) deposition, increased neuronal loss, worsened cognitive deficits, and alterations in microglial responses. We further show that pharmacological activation of CARD9 promotes improved clearance of Abeta deposits from the brains of 5xFAD mice. These results help to establish CARD9 as a key intracellular innate immune signaling molecule that regulates Abeta-mediated disease and microglial responses. Moreover, these findings suggest that targeting CARD9 might offer a strategy to improve Abeta clearance in AD.
37276426	0	5	CARD9	Gene	332579
37276426	17	22	Abeta	Gene	11820
37276426	73	92	Alzheimer's disease	Disease	MESH:D000544
37276426	93	98	mouse	Species	10090
37276426	215	234	Alzheimer's disease	Disease	MESH:D000544
37276426	236	238	AD	Disease	MESH:D000544
37276426	279	281	AD	Disease	MESH:D000544
37276426	282	290	patients	Species	9606
37276426	343	348	TREM2	Gene	54209
37276426	350	354	CD33	Gene	945
37276426	360	364	CD22	Gene	933
37276426	368	393	neurodegenerative disease	Disease	MESH:D019636
37276426	488	490	AD	Disease	MESH:D000544
37276426	613	615	AD	Disease	MESH:D000544
37276426	626	631	TREM2	Gene	83433
37276426	633	637	CD33	Gene	12489
37276426	643	647	CD22	Gene	12483
37276426	742	747	CARD9	Gene	332579
37276426	828	833	CARD9	Gene	332579
37276426	837	839	AD	Disease	MESH:D000544
37276426	906	911	CARD9	Gene	332579
37276426	919	924	5xFAD	Disease	
37276426	925	930	mouse	Species	10090
37276426	940	942	AD	Disease	MESH:D000544
37276426	980	985	Abeta	Gene	11820
37276426	1009	1022	neuronal loss	Disease	MESH:D009410
37276426	1033	1051	cognitive deficits	Disease	MESH:D003072
37276426	1145	1150	CARD9	Gene	332579
37276426	1182	1187	Abeta	Gene	11820
37276426	1216	1221	5xFAD	Disease	
37276426	1222	1226	mice	Species	10090
37276426	1260	1265	CARD9	Gene	332579
37276426	1337	1342	Abeta	Gene	11820
37276426	1434	1439	CARD9	Gene	332579
37276426	1474	1479	Abeta	Gene	11820
37276426	1493	1495	AD	Disease	MESH:D000544
37276426	Positive_Correlation	MESH:D000544	11820
37276426	Negative_Correlation	MESH:D009410	332579
37276426	Negative_Correlation	11820	332579
37276426	Association	12489	332579
37276426	Association	MESH:D000544	54209
37276426	Association	MESH:D000544	332579
37276426	Association	MESH:D019636	933
37276426	Association	12483	332579
37276426	Association	MESH:D019636	54209
37276426	Association	MESH:D000544	945
37276426	Association	MESH:D019636	945
37276426	Association	MESH:D003072	332579
37276426	Association	332579	83433
37276426	Association	MESH:D000544	933

